Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
17.25
-0.35 (-1.99%)
Jul 21, 2026, 3:04 PM CST
SHE:002603 Market Cap
SHE:002603 has a market cap or net worth of 28.82 billion as of July 21, 2026. Its market cap has increased by 13.49% in one year.
Market Cap
28.82B
Enterprise Value
26.41B
Revenue
7.91B
Ranking
n/a
PE Ratio
21.05
Stock Price
17.25
ChartMarket Cap Chart
Since July 28, 2011, SHE:002603's market cap has increased from 18.99B to 28.82B, an increase of 51.77%. That is a compound annual growth rate of 2.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 28.82B | 1.05% |
| Dec 31, 2025 | 28.52B | 6.62% |
| Dec 31, 2024 | 26.75B | -30.60% |
| Dec 29, 2023 | 38.54B | -23.00% |
| Dec 30, 2022 | 50.05B | 52.86% |
| Dec 31, 2021 | 32.75B | 7.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Dong-E-E-Jiao | 31.99B |
| Changchun High-Tech Industry (Group) | 29.12B |
| Dizal (Jiangsu) Pharmaceutical | 28.57B |
| Humanwell Healthcare (Group) | 28.48B |
| Tianjin Pharmaceutical Da Ren Tang Group Corporation | 25.39B |
| Livzon Pharmaceutical Group | 24.79B |
| Betta Pharmaceuticals | 24.36B |
| Hubei Jumpcan Pharmaceutical | 24.19B |